Molecular characterization of interdigitating dendritic cell sarcoma

Interdigitating dendritic cell sarcoma is an extremely rare cancer that lacks a standard treatment approach. We report on a patient who was surgically resected and remains disease- free. The tumor was assessed for druggable targets using immunohistochemical staining to identify potential agents that...

Descripción completa

Detalles Bibliográficos
Autores principales: Weiss, Glen J, Alarcon, Arlet, Halepota, Maqbool, Penny, Robert J, Von Hoff, Daniel D
Formato: Texto
Lenguaje:English
Publicado: PagePress 2010
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994531/
https://www.ncbi.nlm.nih.gov/pubmed/21139965
http://dx.doi.org/10.4081/rt.2010.e50
_version_ 1782192960652181504
author Weiss, Glen J
Alarcon, Arlet
Halepota, Maqbool
Penny, Robert J
Von Hoff, Daniel D
author_facet Weiss, Glen J
Alarcon, Arlet
Halepota, Maqbool
Penny, Robert J
Von Hoff, Daniel D
author_sort Weiss, Glen J
collection PubMed
description Interdigitating dendritic cell sarcoma is an extremely rare cancer that lacks a standard treatment approach. We report on a patient who was surgically resected and remains disease- free. The tumor was assessed for druggable targets using immunohistochemical staining to identify potential agents that could be used in the event of disease recurrence.
format Text
id pubmed-2994531
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher PagePress
record_format MEDLINE/PubMed
spelling pubmed-29945312010-12-07 Molecular characterization of interdigitating dendritic cell sarcoma Weiss, Glen J Alarcon, Arlet Halepota, Maqbool Penny, Robert J Von Hoff, Daniel D Rare Tumors Case Report Interdigitating dendritic cell sarcoma is an extremely rare cancer that lacks a standard treatment approach. We report on a patient who was surgically resected and remains disease- free. The tumor was assessed for druggable targets using immunohistochemical staining to identify potential agents that could be used in the event of disease recurrence. PagePress 2010-09-30 /pmc/articles/PMC2994531/ /pubmed/21139965 http://dx.doi.org/10.4081/rt.2010.e50 Text en ©Copyright G.J. Weiss et al., 2010 This work is licensed under a Creative Commons Attribution 3.0 License (by-nc 3.0). Licensee PAGEPress, Italy
spellingShingle Case Report
Weiss, Glen J
Alarcon, Arlet
Halepota, Maqbool
Penny, Robert J
Von Hoff, Daniel D
Molecular characterization of interdigitating dendritic cell sarcoma
title Molecular characterization of interdigitating dendritic cell sarcoma
title_full Molecular characterization of interdigitating dendritic cell sarcoma
title_fullStr Molecular characterization of interdigitating dendritic cell sarcoma
title_full_unstemmed Molecular characterization of interdigitating dendritic cell sarcoma
title_short Molecular characterization of interdigitating dendritic cell sarcoma
title_sort molecular characterization of interdigitating dendritic cell sarcoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994531/
https://www.ncbi.nlm.nih.gov/pubmed/21139965
http://dx.doi.org/10.4081/rt.2010.e50
work_keys_str_mv AT weissglenj molecularcharacterizationofinterdigitatingdendriticcellsarcoma
AT alarconarlet molecularcharacterizationofinterdigitatingdendriticcellsarcoma
AT halepotamaqbool molecularcharacterizationofinterdigitatingdendriticcellsarcoma
AT pennyrobertj molecularcharacterizationofinterdigitatingdendriticcellsarcoma
AT vonhoffdanield molecularcharacterizationofinterdigitatingdendriticcellsarcoma

Ejemplares similares